Lotus Pharmaceutical Co., Ltd. (TPE:1795)
Taiwan · Delayed Price · Currency is TWD 299.50
-7.50 (-2.44%)
At close: Dec 3, 2025
Lotus Pharmaceutical Market Cap
Lotus Pharmaceutical has a market cap or net worth of 78.89 billion as of December 3, 2025. Its market cap has increased by 13.98% in one year.
Market Cap
78.89B
Enterprise Value
85.64B
Revenue
18.66B
Ranking
n/a
PE Ratio
16.63
Stock Price
299.50
Market Cap Chart
Since August 12, 2014, Lotus Pharmaceutical's market cap has increased from 9.19B to 78.89B, an increase of 758.72%. That is a compound annual growth rate of 20.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 2, 2025 | 80.73B | 12.88% |
| Dec 31, 2024 | 71.52B | -0.57% |
| Dec 29, 2023 | 71.94B | 11.59% |
| Dec 30, 2022 | 64.46B | 152.11% |
| Dec 30, 2021 | 25.57B | 30.27% |
| Dec 31, 2020 | 19.63B | -29.79% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 243.49B |
| PharmaEssentia | 190.84B |
| Bora Pharmaceuticals Co., LTD. | 67.80B |
| Lumosa Therapeutics | 36.64B |
| Lin BioScience | 36.61B |
| Oneness Biotech | 32.53B |
| Center Laboratories | 28.33B |
| Pegavision | 24.22B |